Intrinsic Value of S&P & Nasdaq Contact Us

Alcon Inc. ALC NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • CH • USD

SharesGrow Score
72/100
4/7 Pass
SharesGrow Intrinsic Value
$153.96
+92.6%
Analyst Price Target
$91.02
+13.9%

Alcon Inc. (ALC) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Geneva, Switzerland. The current CEO is David J. Endicott.

ALC has IPO date of 2019-04-09, 25,599 full-time employees, listed on the NYSE, a market capitalization of $38.96B.

About Alcon Inc.

Alcon Inc. is a global eye care company headquartered in Geneva, Switzerland, that researches, develops, manufactures, and distributes a comprehensive portfolio of surgical and vision care products. The company's Surgical segment offers advanced equipment, instrumentation, intraocular lenses, and consumables for cataract, vitreoretinal, refractive, and glaucoma procedures, featuring brands such as Centurion, LenSx, and AcrySof IQ. Its Vision Care segment provides contact lenses, dry eye treatments, glaucoma medications, and ocular health products under well-known brands including DAILIES, Air Optix, and Opti-Free. Founded in 1945 and serving eye care professionals and patients worldwide, Alcon is a leading provider of innovative solutions across surgical and consumer eye care markets.

📍 Chemin de Blandonnet 8, Geneva 1214 📞 41 58 911 20 00
Company Details
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountrySwitzerland
ExchangeNYSE
CurrencyUSD
IPO Date2019-04-09
CEODavid J. Endicott
Employees25,599
Trading Info
Current Price$79.94
Market Cap$38.96B
52-Week Range71.55-99.2
Beta0.74
ETFNo
ADRNo
CUSIPH01301128
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message